Marcela Valko-Rokytovská, M.A., PhD

Last update: 23. 10. 2023

I. BASIC INFORMATION
I.1 Surname Valko-Rokytovská
I.2 Name Marcela
I.3 Titles M.A., PhD
I.4 Year of birth 1980
I.5 Name of the workplace University of Veterinary Medicine and Pharmacy in Košice, Department of Chemistry, Biochemistry and Biophysics
I.6 Address of the workplace Komenského 73, 041 81 Košice, Slovak Republic
I.7 Position lecturer
I.8 E-mail address marcela.valko@uvlf.sk
I.9 Hyperlink to the entry of a person in the Register of university staff https://www.portalvs.sk/regzam/detail/20449
I.10 Name of the study field in which a person works at the university pharmacy
I.11 ORCID iD 3 https://orcid.org/0000-0003-1614-460X
3 Optional item.

II. HIGHER EDUCATION AND FURTHER QUALIFICATION GROWTH
II.a Name of the university or institution II.b Year II.c Study field and programme
II.1 First degree of higher education Pavol Jozef Šafárik University in Košice 2003 chemistry
II.2 Second degree of higher education Pavol Jozef Šafárik University in Košice 2005 chemistry
II.3 Third degree of higher education Pavol Jozef Šafárik University in Košice 2013 clinical biochemistry
II.4 Associate professor
II.5 Professor
II.6 Doctor of Science (DrSc.)

III. CURRENT AND PREVIOUS EMPLOYMENT
III.a Occupation-position III.b Institution III.c Duration
Assistant professor University of Veterinary Medicine and Pharmacy in Košice 2013 2022

IV. DEVELOPMENT OF PEDAGOGICAL, PROFESSIONAL, LANGUAGE, DIGITAL AND OTHER SKILLS
IV.a Activity description, course name, other IV.b Name of the institution IV.c Year

V. OVERVIEW OF ACTIVITIES WITHIN THE TEACHING CAREER AT THE UNIVERSITY
V.1. Overview of the profile courses taught in the current academic year according to study programmes
V.1.a Name of the profile course V.1.b Study programme V.1.c Degree V.1.d Field of study

V.2. Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year 4
V.2.a Study programme V.2.b Degree V.2.d Field of study
4 According to Art. 6 para. 4 of the Standards for the Study Programme.

V.3. Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a Name of the field of habilitation procedure and inaugural procedure V.3.b Study field to which it is assigned

V.4. Overview of supervised final theses
V.4.a Bachelor's (first degree) V.4.b Diploma (second degree) V.4.c Dissertation (third degree)
V.4.1 Number of currently supervised theses 0 2 0
V.4.2 Number of defended theses 1 8 0

V.5. Overview of other courses taught in the current academic year according to study programmes
V.5.a Name of the course V.5.b Study programme V.5.c Degree V.5.d Field of study
Biochemistryfeed and foodstuff safety full time slovak languagefirstveterinary medicine
Biochemistryfeed and foodstuff safety external slovak languagefirstveterinary medicine
Biochemistrypharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy
Clinical and pathological biochemistrypharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy
Biochemistrygeneral veterinary medicine full time slovak languagecombined 1st and 2ndveterinary medicine

VI. OVERVIEW OF THE RESEARCH/ARTISTIC/OTHER OUTPUTS
VI.1. Overview of the research/artistic/other outputs and the corresponding citations
VI.1.a Overall VI.1.b Over the last six years
VI.1.1 Number of the research/artictic/other outputs 52 36
VI.1.2 Number of the research/artictic/other outputs registered in the Web of Science or Scopus databases 8 5
VI.1.3 Number of citations corresponding to the research/artictic/other outputs 31 29
VI.1.4 Number of citations registered in the Web of Science or Scopus databases 26 24
VI.1.5 Number of invited lectures at the international, national level 1 1

VI.2. The most significant research/artistic/other outputs 5
1. VALKO-ROKYTOVSKÁ, Marcela - OČENÁŠ, Peter - SALAYOVÁ, Aneta - KOSTECKÁ, Zuzana. Breast cancer: targeting of steroid hormones in cancerogenesis and diagnostics. In: International Journal of Molecular Sciences. 2021. ISSN 1422-0067, Vol. 22, no. 1 (2021), art. no. 5878, p. [1-15]
(2021: 6.208 - IF, 195 - H-index, 6.628 - IF 5y, 1.176 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q)
2. BIRKOVÁ, Anna - VALKO-ROKYTOVSKÁ, Marcela - HUBKOVÁ, Beáta - ZÁBAVNÍKOVÁ, Marianna - MAREKOVÁ, Mária. Strong dependence between Tryptophan-related fluorescence of urine and malignant melanoma. In: International Journal of Molecular Sciences. 2021. ISSN 1422-0067, Vol. 22, no. 4 (2021), art. no. 1884, p. [1-11]
(2021: 6.208 - IF, 195 - H-index, 6.628 - IF 5y, 1.176 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q)
3. VALKO-ROKYTOVSKÁ, Marcela - OČENÁŠ, Peter - SALAYOVÁ, Aneta - TITKOVÁ, Radka - KOSTECKÁ, Zuzana. Specific urinary metabolites in canine mammary gland tumors. In: Journal of Veterinary Science. 2020. ISSN 1229-845X, Vol. 21, no. 2 (2020), art. no. 23, p. [1-10]
(2020: 1.672 - IF, 47 - H-index, 1.904 - IF 5y, 0.547 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q)
4. VALKO-ROKYTOVSKÁ, Marcela - HUBKOVÁ, Beáta - BIRKOVÁ, Anna - MAŠLANKOVÁ, Jana - STUPÁK, Marek - ZÁBAVNÍKOVÁ, Marianna - ČIŽMÁROVÁ, Beáta - MAREKOVÁ, Mária. Specific urinary metabolites in malignant melanoma : [Špecifické metabolity v moči pri malígnom melanóme] In: Medicina. 2019. ISSN 1010-660X, Vol. 55, no. 5(2019), art. no. 145, p. [1-10]
(2019: 1.205 - IF, 32 - H-index, 1.572 - IF 5y, 0.404 - SJR, Q3 - SJR Best Q, Q3 - JCR Best Q)
5. VALKO-ROKYTOVSKÁ, Marcela - BRUCHATÁ, Katarína - ŠIMKOVÁ, Jana - MILKOVIČOVÁ, Mária - KOSTECKÁ, Zuzana. Current trends in the treatment of malignant melanoma : [Súčasné trendy v liečbe malígneho melanómu] In: Neoplasma. 2016. ISSN 0028-2685, Vol. 63, č. 3(2016), s. 333-341.
(2016: 1.871 - IF, 47 - H-index, 1.772 - IF 5y, 0.714 - SJR, Q3 - SJR Best Q, Q4 - JCR Best Q)
5 Maximum of five most significant outputs, if the RATP form is attached to the application.

VI.3. The most significant research/artistic/other outputs over the last six years 6
1. VALKO-ROKYTOVSKÁ, Marcela - HUBKOVÁ, Beáta - BIRKOVÁ, Anna - MAŠLANKOVÁ, Jana - STUPÁK, Marek - ZÁBAVNÍKOVÁ, Marianna - ČIŽMÁROVÁ, Beáta - MAREKOVÁ, Mária. Specific urinary metabolites in malignant melanoma : [Špecifické metabolity v moči pri malígnom melanóme] In: Medicina. 2019. ISSN 1010-660X, Vol. 55, no. 5(2019), art. no. 145, p. [1-10]
(2019: 1.205 - IF, 32 - H-index, 1.572 - IF 5y, 0.404 - SJR, Q3 - SJR Best Q, Q3 - JCR Best Q)
2. VALKO-ROKYTOVSKÁ, Marcela - BRUCHATÁ, Katarína - ŠIMKOVÁ, Jana - MILKOVIČOVÁ, Mária - KOSTECKÁ, Zuzana. Current trends in the treatment of malignant melanoma : [Súčasné trendy v liečbe malígneho melanómu] In: Neoplasma. 2016. ISSN 0028-2685, Vol. 63, č. 3(2016), s. 333-341.
(2016: 1.871 - IF, 47 - H-index, 1.772 - IF 5y, 0.714 - SJR, Q3 - SJR Best Q, Q4 - JCR Best Q)
3. VALKO-ROKYTOVSKÁ, Marcela - OČENÁŠ, Peter - SALAYOVÁ, Aneta - KOSTECKÁ, Zuzana. Breast cancer: targeting of steroid hormones in cancerogenesis and diagnostics. In: International Journal of Molecular Sciences. 2021. ISSN 1422-0067, Vol. 22, no. 1 (2021), art. no. 5878, p. [1-15]
(2021: 6.208 - IF, 195 - H-index, 6.628 - IF 5y, 1.176 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q)
4. BIRKOVÁ, Anna - VALKO-ROKYTOVSKÁ, Marcela - HUBKOVÁ, Beáta - ZÁBAVNÍKOVÁ, Marianna - MAREKOVÁ, Mária. Strong dependence between Tryptophan-related fluorescence of urine and malignant melanoma. In: International Journal of Molecular Sciences. 2021. ISSN 1422-0067, Vol. 22, no. 4 (2021), art. no. 1884, p. [1-11]
(2021: 6.208 - IF, 195 - H-index, 6.628 - IF 5y, 1.176 - SJR, Q1 - SJR Best Q, Q1 - JCR Best Q)
5. VALKO-ROKYTOVSKÁ, Marcela - OČENÁŠ, Peter - SALAYOVÁ, Aneta - TITKOVÁ, Radka - KOSTECKÁ, Zuzana. Specific urinary metabolites in canine mammary gland tumors. In: Journal of Veterinary Science. 2020. ISSN 1229-845X, Vol. 21, no. 2 (2020), art. no. 23, p. [1-10]
(2020: 1.672 - IF, 47 - H-index, 1.904 - IF 5y, 0.547 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q)
6 Maximum of five most significant outputs over the last six years, if the RATP form is attached to the application.

VI.4. The most significant citations corresponding to the research/artistic/other outputs 7
1. VALKO-ROKYTOVSKÁ, Marcela - BRUCHATÁ, Katarína - ŠIMKOVÁ, Jana - MILKOVIČOVÁ, Mária - KOSTECKÁ, Zuzana. Current trends in the treatment of malignant melanoma : [Súčasné trendy v liečbe malígneho melanómu] In: Neoplasma. 2016. ISSN 0028-2685, Vol. 63, č. 3(2016), s. 333-341.
(2016: 1.871 - IF, 47 - H-index, 1.772 - IF 5y, 0.714 - SJR, Q3 - SJR Best Q, Q4 - JCR Best Q)
[1] YANG, Yanwen - QI, Fazhi - WEI, Chuanyuan - LIU, Jiaqi - ZHANG, Yong - LUAN, Wenjie - GU, Jianying. PSMC2 knockdown suppressed tumor progression of skin cutaneous melanoma. In CELL DEATH DISCOVERY, 2021, vol. 7, no. 1, pp.
2. VALKO-ROKYTOVSKÁ, Marcela - BRUCHATÁ, Katarína - ŠIMKOVÁ, Jana - MILKOVIČOVÁ, Mária - KOSTECKÁ, Zuzana. Current trends in the treatment of malignant melanoma : [Súčasné trendy v liečbe malígneho melanómu] In: Neoplasma. 2016. ISSN 0028-2685, Vol. 63, č. 3(2016), s. 333-341.
(2016: 1.871 - IF, 47 - H-index, 1.772 - IF 5y, 0.714 - SJR, Q3 - SJR Best Q, Q4 - JCR Best Q)
[1] ROSERO, Rebecca A. - VILLARES, Gabriel J. - BAR-ELI, Menashe. Protease-activated receptors and other G-protein-coupled receptors: The melanoma connection. In Frontiers in Genetics, 2016-06-15, 7, jUN, pp.
3. VALKO-ROKYTOVSKÁ, Marcela - BRUCHATÁ, Katarína - ŠIMKOVÁ, Jana - MILKOVIČOVÁ, Mária - KOSTECKÁ, Zuzana. Current trends in the treatment of malignant melanoma : [Súčasné trendy v liečbe malígneho melanómu] In: Neoplasma. 2016. ISSN 0028-2685, Vol. 63, č. 3(2016), s. 333-341.
(2016: 1.871 - IF, 47 - H-index, 1.772 - IF 5y, 0.714 - SJR, Q3 - SJR Best Q, Q4 - JCR Best Q)
[1] KWON, Ji Young - SEO, Ji Ye - KIM, Tae Yun - LEE, Hee Il - JU, Jung Won. First identification and genotyping of enterocytozoon bieneusi and prevalence of encephalitozoon intestinalis in patients with acute diarrhea in the republic of korea. In Pathogens, 2021-11-01, 10, 11, pp.
4. VALKO-ROKYTOVSKÁ, Marcela - BRUCHATÁ, Katarína - ŠIMKOVÁ, Jana - MILKOVIČOVÁ, Mária - KOSTECKÁ, Zuzana. Current trends in the treatment of malignant melanoma : [Súčasné trendy v liečbe malígneho melanómu] In: Neoplasma. 2016. ISSN 0028-2685, Vol. 63, č. 3(2016), s. 333-341.
(2016: 1.871 - IF, 47 - H-index, 1.772 - IF 5y, 0.714 - SJR, Q3 - SJR Best Q, Q4 - JCR Best Q)
[1] SHEN, Congcong - HUA, Hui - GU, Lixiong - CAO, Shuanglin - CAI, Hengji - YAO, Xiaodong - CHEN, Xiaodong. Overexpression of RACK1 Predicts Poor Prognosis in Melanoma. In JOURNAL OF CANCER. ISSN 1837-9664, 2020, vol. 11, no. 4, pp. 795-803.
5. VALKO-ROKYTOVSKÁ, Marcela - HUBKOVÁ, Beáta - BIRKOVÁ, Anna - MAŠLANKOVÁ, Jana - STUPÁK, Marek - ZÁBAVNÍKOVÁ, Marianna - ČIŽMÁROVÁ, Beáta - MAREKOVÁ, Mária. Specific urinary metabolites in malignant melanoma : [Špecifické metabolity v moči pri malígnom melanóme] In: Medicina. 2019. ISSN 1010-660X, Vol. 55, no. 5(2019), art. no. 145, p. [1-10]
(2019: 1.205 - IF, 32 - H-index, 1.572 - IF 5y, 0.404 - SJR, Q3 - SJR Best Q, Q3 - JCR Best Q)
[1] WAKAMATSU, Kazumasa - FUKUSHIMA, Satoshi - MINAGAWA, Akane - OMODAKA, Toshikazu - HIDA, Tokimasa - HATTA, Naohito - TAKATA, Minoru - UHARA, Hisashi - OKUYAMA, Ryuhei - IHN, Hironobu. Significance of 5-S-Cysteinyldopa as a Marker for Melanoma. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, vol. 21, no. 2, pp.
7 Maximum of five most significant citations, if the RATP form is attached to the application.

VI.5. Participation in conducting (leading) the most important research projects or art projects over the last six years 8
1. VEGA 1/0454/22 "Study of the possibilities of using humic substances in combination with autochthonous probiotic bee lactobacilli to improve the health of honeybees and the quality of bee products", Duration: 2022 - 2025
2. KEGA 015UVLF-4/2022 "Innovation of Clinical and Pathological Biochemistry in study programme Pharmacy", Duration: 2022 - 2024
8 Maximum of five most significant projects, if the RATP form is attached to the application. In addition to the name and brief characteristics of the project, the type of participation is indicated (in Slovak and in English), if possible, a hyperlink to the project and its outputs and citations are stated as well.

VII. OVERVIEW OF ORGANIZATIONAL EXPERIENCE RELATED TO HIGHER EDUCATION AND RESEARCH/ARTISTIC/OTHER ACTIVITIES 9
VII.a Activity, position VII.b Name of the institution, board VII.c Duration
9 E.g. academic positions, memberships in editorial boards and in scientific and professional societies.

VIII. OVERVIEW OF INTERNATIONAL MOBILITIES AND VISITS ORIENTED ON EDUCATION AND RESEARCH/ARTISTIC/ OTHER ACTIVITIES IN THE GIVEN FIELD OF STUDY
VIII.a Name of the institution VIII.b Address of the institution VIII.c Duration (indicate the duration of stay) VIII.d Mobility scheme, employment contract, other (describe)

IX. OTHER RELEVANT FACTS 10
IX.a If relevant, other activities related to higher education or research/artictic/other activities are mentioned
10 Maximum of 1800 characters, if the RATP form is attached to the application.
Skip to content